View Financial HealthGenomma Lab Internacional. de 配当と自社株買い配当金 基準チェック /46Genomma Lab Internacional. de配当を支払う会社であり、現在の利回りは5.22%で、収益によって十分にカバーされています。主要情報5.2%配当利回り0.1%バイバック利回り総株主利回り5.3%将来の配当利回り8.8%配当成長20.4%次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向36%最近の配当と自社株買いの更新お知らせ • Dec 09Genomma Lab Internacional Announces Fourteenth Dividend Payment, Payable on December 23, 2025Genomma Lab Internacional, S.A.B. de C.V. informs that the Company presented a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Currency), payable to shareholders of record of the applicable circulating shares at the close of business on December 23, 2025. This amount per share is based on the total LABB shares currently outstanding.お知らせ • Jun 24Genomma Lab Internacional, S.A.B. De C.V. Announces Twelfth Quarterly Dividend Payment, Payable on July 1, 2025Genomma Lab Internacional, S.A.B. de C.V. informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Currency), payable to shareholders of record of the applicable circulating shares at the close of business on July 1st, 2025. This amount per share is based on the total LABB shares currently outstanding. Subject to the terms and conditions established by the AGSM, the Company has the intention to make dividend payments on a Quarterly basis.お知らせ • Mar 07Genomma Lab Internacional Announces Eleventh Cash Dividend PaymentGenomma Lab Internacional, S.A.B. de C.V. informed that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Currency), payable to shareholders of record of the applicable circulating shares at the close of business on March 14, 2025. This amount per share is based on the total LABB shares currently outstanding. Genomma's Board of Directors, exercising the powers delegated at the Annual General Shareholders Meeting held on April 30, 2024 ("AGSM"), have therefore deemed it appropriate to make this announced dividend payment. Subject to the terms and conditions established by the AGSM, the Company has the intention to make dividend payments on a Quarterly basis.お知らせ • Jun 16Genomma Lab Internacional, S.A.B. De C.V. Declares Cash DividendGenomma Lab Internacional, S.A.B. de C.V. informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N., payable to shareholders of record of the applicable circulating shares at the close of business on June 21, 2024. This amount per share is based on the total LABB shares currently outstanding. Genomma's Board of Directors, exercising the powers delegated at the Annual General Shareholders Meeting held on April 30, 2024, have therefore deemed it appropriate to make this announced dividend payment.お知らせ • Mar 14Genomma Lab Internacional, S.A.B. De C.V. Declares Cash DividendGenomma Lab Internacional, S.A.B. de C.V. informed that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of MXN 0.196080 per share on its common stock representing a total amount of MXN 200,001,600.00 payable to shareholders of record of the applicable circulating shares at the close of business on March 25, 2024. This amount per share is based on the total LABB shares currently outstanding. Genomma's Board of Directors, exercising the powers delegated at the Annual General Shareholders Meeting held on April 28, 2023 (AGSM), have therefore deemed it appropriate to make this seventh announced dividend payment.お知らせ • Dec 14Genomma Lab Internacional, S.A.B. De C.V. Announces Sixth Dividend PaymentGenomma Lab Internacional, S.A.B. de C.V. (Genomma Lab) informed that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of MXN 0.196080 per share on its common stock representing a total amount of MXN 200,001,600.00, payable to shareholders of record of the applicable circulating shares at the close of business on December 27, 2023.すべての更新を表示Recent updatesお知らせ • Apr 14+ 1 more updateGenomma Lab Internacional, S.A.B. de C.V., Annual General Meeting, Apr 29, 2026Genomma Lab Internacional, S.A.B. de C.V., Annual General Meeting, Apr 29, 2026. Location: antonio dovali jaime no 70, tower c 2nd floor, santa fe neighborhood, cp 01210, mexico Mexicoお知らせ • Jan 30Genomma Lab Internacional, S.A.B. de C.V. to Report Q4, 2025 Results on Feb 25, 2026Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q4, 2025 results After-Market on Feb 25, 2026お知らせ • Dec 09Genomma Lab Internacional Announces Fourteenth Dividend Payment, Payable on December 23, 2025Genomma Lab Internacional, S.A.B. de C.V. informs that the Company presented a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Currency), payable to shareholders of record of the applicable circulating shares at the close of business on December 23, 2025. This amount per share is based on the total LABB shares currently outstanding.お知らせ • Oct 09Genomma Lab Internacional, S.A.B. de C.V. to Report Q3, 2025 Results on Oct 22, 2025Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q3, 2025 results After-Market on Oct 22, 2025お知らせ • Jun 30Genomma Lab Internacional, S.A.B. de C.V. to Report Q2, 2025 Results on Jul 23, 2025Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q2, 2025 results After-Market on Jul 23, 2025お知らせ • Jun 24Genomma Lab Internacional, S.A.B. De C.V. Announces Twelfth Quarterly Dividend Payment, Payable on July 1, 2025Genomma Lab Internacional, S.A.B. de C.V. informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Currency), payable to shareholders of record of the applicable circulating shares at the close of business on July 1st, 2025. This amount per share is based on the total LABB shares currently outstanding. Subject to the terms and conditions established by the AGSM, the Company has the intention to make dividend payments on a Quarterly basis.お知らせ • Apr 08Genomma Lab Internacional, S.A.B. de C.V., Annual General Meeting, Apr 24, 2025Genomma Lab Internacional, S.A.B. de C.V., Annual General Meeting, Apr 24, 2025. Location: antonio dovali jaime no 70, tower c 2nd floor, santa fe neighborhood, cp 01210, mexico Mexicoお知らせ • Apr 01Genomma Lab Internacional, S.A.B. de C.V. to Report Q1, 2025 Results on Apr 30, 2025Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q1, 2025 results After-Market on Apr 30, 2025お知らせ • Mar 07Genomma Lab Internacional Announces Eleventh Cash Dividend PaymentGenomma Lab Internacional, S.A.B. de C.V. informed that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Currency), payable to shareholders of record of the applicable circulating shares at the close of business on March 14, 2025. This amount per share is based on the total LABB shares currently outstanding. Genomma's Board of Directors, exercising the powers delegated at the Annual General Shareholders Meeting held on April 30, 2024 ("AGSM"), have therefore deemed it appropriate to make this announced dividend payment. Subject to the terms and conditions established by the AGSM, the Company has the intention to make dividend payments on a Quarterly basis.お知らせ • Feb 11Genomma Lab Internacional, S.A.B. de C.V. to Report Q4, 2024 Results on Feb 26, 2025Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q4, 2024 results at 3:00 PM, Central Standard Time on Feb 26, 2025お知らせ • Oct 05Genomma Lab Internacional, S.A.B. de C.V. to Report Q3, 2024 Results on Oct 23, 2024Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q3, 2024 results After-Market on Oct 23, 2024お知らせ • Oct 03Genomma Lab Pharma Manufacturing Facility Receives Pending GMP Certification for the Mexican Market from the Mexican Ministry of Health's Federal CommitteeGenomma Lab Internacional, S.A.B. de C.V. announced that it has received Good Manufacturing Practices ("GMP") certification from the Mexican Ministry of Health's Federal Committee for Protection from Sanitary Risks for its oral liquid, topical liquid and tablet coating manufacturing production at Genomma Lab's Medicinas y Medicamentos Nacionales, S.A. de C.V. manufacturing facility in the State of Mexico.お知らせ • Jul 04Genomma Lab Internacional, S.A.B. de C.V. to Report Q2, 2024 Results on Jul 24, 2024Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q2, 2024 results After-Market on Jul 24, 2024お知らせ • Jun 16Genomma Lab Internacional, S.A.B. De C.V. Declares Cash DividendGenomma Lab Internacional, S.A.B. de C.V. informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N., payable to shareholders of record of the applicable circulating shares at the close of business on June 21, 2024. This amount per share is based on the total LABB shares currently outstanding. Genomma's Board of Directors, exercising the powers delegated at the Annual General Shareholders Meeting held on April 30, 2024, have therefore deemed it appropriate to make this announced dividend payment.お知らせ • Apr 05Genomma Lab Internacional, S.A.B. de C.V. to Report Q1, 2024 Results on Apr 24, 2024Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q1, 2024 results After-Market on Apr 24, 2024お知らせ • Mar 14Genomma Lab Internacional, S.A.B. De C.V. Declares Cash DividendGenomma Lab Internacional, S.A.B. de C.V. informed that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of MXN 0.196080 per share on its common stock representing a total amount of MXN 200,001,600.00 payable to shareholders of record of the applicable circulating shares at the close of business on March 25, 2024. This amount per share is based on the total LABB shares currently outstanding. Genomma's Board of Directors, exercising the powers delegated at the Annual General Shareholders Meeting held on April 28, 2023 (AGSM), have therefore deemed it appropriate to make this seventh announced dividend payment.お知らせ • Jan 24Genomma Lab Internacional, S.A.B. de C.V. to Report Q4, 2023 Results on Feb 21, 2024Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q4, 2023 results After-Market on Feb 21, 2024お知らせ • Dec 14Genomma Lab Internacional, S.A.B. De C.V. Announces Sixth Dividend PaymentGenomma Lab Internacional, S.A.B. de C.V. (Genomma Lab) informed that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of MXN 0.196080 per share on its common stock representing a total amount of MXN 200,001,600.00, payable to shareholders of record of the applicable circulating shares at the close of business on December 27, 2023.お知らせ • Oct 05Genomma Lab Internacional, S.A.B. de C.V. to Report Q3, 2023 Results on Oct 25, 2023Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q3, 2023 results After-Market on Oct 25, 2023お知らせ • Jul 06Genomma Lab Internacional, S.A.B. de C.V. to Report Q2, 2023 Results on Jul 26, 2023Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q2, 2023 results After-Market on Jul 26, 2023お知らせ • Jan 31Genomma Lab Internacional, S.A.B. de C.V. to Report Q4, 2022 Results on Feb 22, 2023Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q4, 2022 results After-Market on Feb 22, 2023決済の安定と成長配当データの取得安定した配当: 配当金の支払いは安定していますが、 GNML.Fが配当金を支払っている期間は 10 年未満です。増加する配当: GNML.Fの配当金は増加していますが、同社は5年間しか配当金を支払っていません。配当利回り対市場Genomma Lab Internacional. de 配当利回り対市場GNML.F 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (GNML.F)5.2%市場下位25% (US)1.4%市場トップ25% (US)4.2%業界平均 (Pharmaceuticals)2.0%アナリスト予想 (GNML.F) (最長3年)8.8%注目すべき配当: GNML.Fの配当金 ( 5.22% ) はUS市場の配当金支払者の下位 25% ( 1.42% ) よりも高くなっています。高配当: GNML.Fの配当金 ( 5.22% ) はUS市場 ( 4.25% ) の配当支払者の中で上位 25% に入っています。株主への利益配当収益カバレッジ: GNML.Fの 配当性向 ( 36.4% ) はかなり低いため、配当金の支払いは利益によって十分にカバーされます。株主配当金キャッシュフローカバレッジ: GNML.Fは合理的な 現金配当性向 ( 55.2% ) を備えているため、配当金の支払いはキャッシュフローによって賄われます。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/05 11:14終値2026/04/09 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Genomma Lab Internacional, S.A.B. de C.V. 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。13 アナリスト機関Antonio Hernandez Velez LeijaActinver Case de Bolsa, S.A. de C.V.Benjamin TheurerBarclaysRobert Ford AguilarBofA Global Research10 その他のアナリストを表示
お知らせ • Dec 09Genomma Lab Internacional Announces Fourteenth Dividend Payment, Payable on December 23, 2025Genomma Lab Internacional, S.A.B. de C.V. informs that the Company presented a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Currency), payable to shareholders of record of the applicable circulating shares at the close of business on December 23, 2025. This amount per share is based on the total LABB shares currently outstanding.
お知らせ • Jun 24Genomma Lab Internacional, S.A.B. De C.V. Announces Twelfth Quarterly Dividend Payment, Payable on July 1, 2025Genomma Lab Internacional, S.A.B. de C.V. informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Currency), payable to shareholders of record of the applicable circulating shares at the close of business on July 1st, 2025. This amount per share is based on the total LABB shares currently outstanding. Subject to the terms and conditions established by the AGSM, the Company has the intention to make dividend payments on a Quarterly basis.
お知らせ • Mar 07Genomma Lab Internacional Announces Eleventh Cash Dividend PaymentGenomma Lab Internacional, S.A.B. de C.V. informed that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Currency), payable to shareholders of record of the applicable circulating shares at the close of business on March 14, 2025. This amount per share is based on the total LABB shares currently outstanding. Genomma's Board of Directors, exercising the powers delegated at the Annual General Shareholders Meeting held on April 30, 2024 ("AGSM"), have therefore deemed it appropriate to make this announced dividend payment. Subject to the terms and conditions established by the AGSM, the Company has the intention to make dividend payments on a Quarterly basis.
お知らせ • Jun 16Genomma Lab Internacional, S.A.B. De C.V. Declares Cash DividendGenomma Lab Internacional, S.A.B. de C.V. informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N., payable to shareholders of record of the applicable circulating shares at the close of business on June 21, 2024. This amount per share is based on the total LABB shares currently outstanding. Genomma's Board of Directors, exercising the powers delegated at the Annual General Shareholders Meeting held on April 30, 2024, have therefore deemed it appropriate to make this announced dividend payment.
お知らせ • Mar 14Genomma Lab Internacional, S.A.B. De C.V. Declares Cash DividendGenomma Lab Internacional, S.A.B. de C.V. informed that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of MXN 0.196080 per share on its common stock representing a total amount of MXN 200,001,600.00 payable to shareholders of record of the applicable circulating shares at the close of business on March 25, 2024. This amount per share is based on the total LABB shares currently outstanding. Genomma's Board of Directors, exercising the powers delegated at the Annual General Shareholders Meeting held on April 28, 2023 (AGSM), have therefore deemed it appropriate to make this seventh announced dividend payment.
お知らせ • Dec 14Genomma Lab Internacional, S.A.B. De C.V. Announces Sixth Dividend PaymentGenomma Lab Internacional, S.A.B. de C.V. (Genomma Lab) informed that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of MXN 0.196080 per share on its common stock representing a total amount of MXN 200,001,600.00, payable to shareholders of record of the applicable circulating shares at the close of business on December 27, 2023.
お知らせ • Apr 14+ 1 more updateGenomma Lab Internacional, S.A.B. de C.V., Annual General Meeting, Apr 29, 2026Genomma Lab Internacional, S.A.B. de C.V., Annual General Meeting, Apr 29, 2026. Location: antonio dovali jaime no 70, tower c 2nd floor, santa fe neighborhood, cp 01210, mexico Mexico
お知らせ • Jan 30Genomma Lab Internacional, S.A.B. de C.V. to Report Q4, 2025 Results on Feb 25, 2026Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q4, 2025 results After-Market on Feb 25, 2026
お知らせ • Dec 09Genomma Lab Internacional Announces Fourteenth Dividend Payment, Payable on December 23, 2025Genomma Lab Internacional, S.A.B. de C.V. informs that the Company presented a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Currency), payable to shareholders of record of the applicable circulating shares at the close of business on December 23, 2025. This amount per share is based on the total LABB shares currently outstanding.
お知らせ • Oct 09Genomma Lab Internacional, S.A.B. de C.V. to Report Q3, 2025 Results on Oct 22, 2025Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q3, 2025 results After-Market on Oct 22, 2025
お知らせ • Jun 30Genomma Lab Internacional, S.A.B. de C.V. to Report Q2, 2025 Results on Jul 23, 2025Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q2, 2025 results After-Market on Jul 23, 2025
お知らせ • Jun 24Genomma Lab Internacional, S.A.B. De C.V. Announces Twelfth Quarterly Dividend Payment, Payable on July 1, 2025Genomma Lab Internacional, S.A.B. de C.V. informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Currency), payable to shareholders of record of the applicable circulating shares at the close of business on July 1st, 2025. This amount per share is based on the total LABB shares currently outstanding. Subject to the terms and conditions established by the AGSM, the Company has the intention to make dividend payments on a Quarterly basis.
お知らせ • Apr 08Genomma Lab Internacional, S.A.B. de C.V., Annual General Meeting, Apr 24, 2025Genomma Lab Internacional, S.A.B. de C.V., Annual General Meeting, Apr 24, 2025. Location: antonio dovali jaime no 70, tower c 2nd floor, santa fe neighborhood, cp 01210, mexico Mexico
お知らせ • Apr 01Genomma Lab Internacional, S.A.B. de C.V. to Report Q1, 2025 Results on Apr 30, 2025Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q1, 2025 results After-Market on Apr 30, 2025
お知らせ • Mar 07Genomma Lab Internacional Announces Eleventh Cash Dividend PaymentGenomma Lab Internacional, S.A.B. de C.V. informed that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N. (two hundred million pesos 00/100 National Currency), payable to shareholders of record of the applicable circulating shares at the close of business on March 14, 2025. This amount per share is based on the total LABB shares currently outstanding. Genomma's Board of Directors, exercising the powers delegated at the Annual General Shareholders Meeting held on April 30, 2024 ("AGSM"), have therefore deemed it appropriate to make this announced dividend payment. Subject to the terms and conditions established by the AGSM, the Company has the intention to make dividend payments on a Quarterly basis.
お知らせ • Feb 11Genomma Lab Internacional, S.A.B. de C.V. to Report Q4, 2024 Results on Feb 26, 2025Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q4, 2024 results at 3:00 PM, Central Standard Time on Feb 26, 2025
お知らせ • Oct 05Genomma Lab Internacional, S.A.B. de C.V. to Report Q3, 2024 Results on Oct 23, 2024Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q3, 2024 results After-Market on Oct 23, 2024
お知らせ • Oct 03Genomma Lab Pharma Manufacturing Facility Receives Pending GMP Certification for the Mexican Market from the Mexican Ministry of Health's Federal CommitteeGenomma Lab Internacional, S.A.B. de C.V. announced that it has received Good Manufacturing Practices ("GMP") certification from the Mexican Ministry of Health's Federal Committee for Protection from Sanitary Risks for its oral liquid, topical liquid and tablet coating manufacturing production at Genomma Lab's Medicinas y Medicamentos Nacionales, S.A. de C.V. manufacturing facility in the State of Mexico.
お知らせ • Jul 04Genomma Lab Internacional, S.A.B. de C.V. to Report Q2, 2024 Results on Jul 24, 2024Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q2, 2024 results After-Market on Jul 24, 2024
お知らせ • Jun 16Genomma Lab Internacional, S.A.B. De C.V. Declares Cash DividendGenomma Lab Internacional, S.A.B. de C.V. informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.200000 Mexican pesos per share on its common stock representing a total amount of $200,000,000.00 M.N., payable to shareholders of record of the applicable circulating shares at the close of business on June 21, 2024. This amount per share is based on the total LABB shares currently outstanding. Genomma's Board of Directors, exercising the powers delegated at the Annual General Shareholders Meeting held on April 30, 2024, have therefore deemed it appropriate to make this announced dividend payment.
お知らせ • Apr 05Genomma Lab Internacional, S.A.B. de C.V. to Report Q1, 2024 Results on Apr 24, 2024Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q1, 2024 results After-Market on Apr 24, 2024
お知らせ • Mar 14Genomma Lab Internacional, S.A.B. De C.V. Declares Cash DividendGenomma Lab Internacional, S.A.B. de C.V. informed that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of MXN 0.196080 per share on its common stock representing a total amount of MXN 200,001,600.00 payable to shareholders of record of the applicable circulating shares at the close of business on March 25, 2024. This amount per share is based on the total LABB shares currently outstanding. Genomma's Board of Directors, exercising the powers delegated at the Annual General Shareholders Meeting held on April 28, 2023 (AGSM), have therefore deemed it appropriate to make this seventh announced dividend payment.
お知らせ • Jan 24Genomma Lab Internacional, S.A.B. de C.V. to Report Q4, 2023 Results on Feb 21, 2024Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q4, 2023 results After-Market on Feb 21, 2024
お知らせ • Dec 14Genomma Lab Internacional, S.A.B. De C.V. Announces Sixth Dividend PaymentGenomma Lab Internacional, S.A.B. de C.V. (Genomma Lab) informed that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of MXN 0.196080 per share on its common stock representing a total amount of MXN 200,001,600.00, payable to shareholders of record of the applicable circulating shares at the close of business on December 27, 2023.
お知らせ • Oct 05Genomma Lab Internacional, S.A.B. de C.V. to Report Q3, 2023 Results on Oct 25, 2023Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q3, 2023 results After-Market on Oct 25, 2023
お知らせ • Jul 06Genomma Lab Internacional, S.A.B. de C.V. to Report Q2, 2023 Results on Jul 26, 2023Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q2, 2023 results After-Market on Jul 26, 2023
お知らせ • Jan 31Genomma Lab Internacional, S.A.B. de C.V. to Report Q4, 2022 Results on Feb 22, 2023Genomma Lab Internacional, S.A.B. de C.V. announced that they will report Q4, 2022 results After-Market on Feb 22, 2023